On January 7, 2016, Taunia Markvicka terminated her employment as Senior Vice President, Commercial Strategy of Pacira Pharmaceuticals, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.19 USD | +3.11% | -2.69% | -16.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.45% | 1.27B | |
+52.93% | 797B | |
+40.55% | 628B | |
-7.08% | 351B | |
+17.40% | 323B | |
+10.58% | 300B | |
+17.13% | 244B | |
+1.39% | 223B | |
+6.24% | 163B | |
-4.79% | 153B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Pacira Pharmaceuticals, Inc. Announces Termination of Taunia Markvicka as Senior Vice President, Commercial Strategy